ACAD News and Press, ACADIA Pharmaceuticals Inc.

Issued on behalf of Cybin D/B/A Helus Pharma VANCOUVER — Baystreet.ca News Commentary — The convergence of precision medicine, novel mechanisms, and regulatory support is driving a renaissance in neuropsychiatric drug development 1 . Federal production quotas for c...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Jonathan M. Poole to its Board of Directors, effective March 3, 2026. Mr. Poole will serve on the Company’s Audit Committee and brings deep biopharmaceutical finance leadership experience in supporting global gro...

2026-03-02 20:03:59 ET from William Blair issued a price target of $29.00 for ACAD on 2026-03-02 21:56:00. The adjusted price target was set to $29.00. At the time of the announcement, ACAD was trading at $22.81. The overall price target consensus is at $34.78 with high ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) informed the company it has formally adopted a negative opinion regarding the Marketing Authorization Application for trofinetide fo...

2026-02-28 08:58:59 ET I have followed and chronicled the ups and downs of ACADIA Pharmaceuticals ( ACAD ) since 07/2017's "Acadia: Order For Central Nervous Systems In Need". My most recent Acadia article focusing exclusively on Acadia was 10/2022's "Acadia Pharmaceuticals: Nuplazi...

Issued on behalf of Helus Pharma VANCOUVER – Baystreet.ca News Commentary – A growing body of clinical evidence is pushing neuroscience-based therapies from early research into late-stage development, with multiple compounds now approaching regulatory milestones acro...

2026-02-26 01:58:25 ET More on Acadia Pharma ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript ACADIA Pharmaceuticals Inc. 2025 Q4 - Results - Earnings Call Presentation 44th Annual J.P. Morgan Healthcare Conference Seeking Alpha’s Qu...

2026-02-26 01:57:48 ET ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call Transcript

2026-02-25 18:38:23 ET Image source: The Motley Fool. Wednesday, February 25, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-25 16:19:16 ET More on Acadia Pharma 44th Annual J.P. Morgan Healthcare Conference ACADIA Pharmaceuticals Inc. (ACAD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Buy Acadia Pharmaceuticals For Daybue/Nuplazid Stability And Pipeline Op...